This episode delves into the evolving landscape of brain metastases treatment, focusing on the integration of stereotactic radiotherapy with novel systemic agents. We examine the "Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy" study, published in Clinical oncology in 2026, as an abstract. The research evaluates the safety, local control, and overall efficacy of combining CyberKnife stereotactic radiosurgery/radiotherapy with immunotherapy or targeted therapy in adult patients with brain metastases from advanced solid cancers. Key findings and their implications for clinical practice are discussed, highlighting potential synergistic benefits and challenges of this combined approach. This AI-generated summary is for informational purposes and not a substitute for professional medical advice.